SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : analysts and calls -- B of A

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: scaram(o)uche6/21/2007 10:57:44 AM
   of 33
 
Bank of America Expands Equity Research Coverage with Addition of Biotech Analyst Katherine S. Kim
Thursday June 21, 10:00 am ET

NEW YORK, June 21 /PRNewswire/ -- Bank of America today announced that Katherine S. Kim has joined Banc of America Securities as a principal and senior equity research analyst covering biotechnology stocks. She will be based in New York and will report to Robert Fagin, Associate Director, Equity Research.

"Katherine is a welcome addition to our strong Healthcare platform and we look forward to the role she will play in expanding our biotech stock coverage," said Paula Dominick, Global Head of Research. "Adding top research talent is an important part of our commitment to providing investor clients with actionable investment ideas across a broad array of industries and sectors."

Katherine Kim will head the biotechnology team effort, which also includes senior equity research analysts William Ho, John Watkins and William Sargent. The broader Healthcare team is now comprised of 13 senior research analysts covering the following subsectors: Biotechnology, Diagnostic & Research Supplies, Health Care Facilities, Health Care Technology & Distribution, Large-Cap Pharmaceuticals, Managed Care, Medical Supplies & Devices and Specialty Pharmaceuticals. In recent years, Bank of America's Equity Research Department has enjoyed increased recognition by the institutional investor community for the quality of its investment research, underscored by a jump from eleventh to sixth place over the last two years in the Institutional Investor ranking of Wall Street equity research platforms.

Previously, Katherine Kim was a senior analyst at ThinkEquity Partners and C.E. Unterberg Towbin, where she covered small-and mid-cap biotechnology stocks. Prior to that, she was a research analyst at UBS.

She received a master of business administration degree with a concentration in finance from New York University's Leonard Stern N. School of Business and a bachelor of arts degree in biology and economics from Binghamton University.

Bank of America

Bank of America (NYSE: BAC - News) is one of the world's largest financial institutions, serving individual consumers, small and middle market businesses and large corporations with a full range of banking, investing, asset management and other financial products and services. The company's Global Corporate and Investment Banking group (GCIB) focuses on companies with annual revenues of more than $2.5 million; middle-market and large corporations; institutional investors; financial institutions; and government entities. GCIB provides innovative services in M&A, equity and debt capital raising, lending, trading, risk management, treasury management and research. Bank of America serves clients in 175 countries and has relationships with 98 percent of the U.S. Fortune 500 companies and 79 percent of the Global Fortune 500. Many of the bank's services to corporate and institutional clients are provided through its U.S. and UK subsidiaries, Banc of America Securities LLC and Banc of America Securities Limited. For additional information, visit bankofamerica.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext